Telo Genomics Corp (TSE:TELO) has released an update.
Telo Genomics Corp. has announced a non-brokered private placement aiming to raise up to $600,000 by selling units at $0.20 each, with each unit including a common share and a half warrant, entitling holders to buy additional shares at $0.40. The proceeds will bolster general working capital, and the securities will be subject to a four-month hold period post-issuance. Finder’s fees may apply to the transaction, which is pending TSX Venture Exchange acceptance.
For further insights into TSE:TELO stock, check out TipRanks’ Stock Analysis page.
